Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Loading...
April 24, 2024
Actiphage® TB, a novel phage-based diagnostic, is set to revolutionise the testing and treatment of tuberculosis.
Actiphage® TB, a novel phage-based diagnostic, is set to revolutionise the testing and treatment of tuberculosis.
April 24, 2024
Donated frozen PBMC samples will help accelerate development of new TB diagnostic.
Donated frozen PBMC samples will help accelerate development of new TB diagnostic.
April 3, 2024
We are delighted to announce that PBD Biotech has achieved ISO 13485 accreditation for the development and manufacture of diagnostic kits.
April 3, 2024
We are delighted to announce that PBD Biotech has achieved ISO 13485 accreditation for the development and manufacture of diagnostic...
March 22, 2024
World TB Day 2024 is a moment to take stock of developments in the fight to end tuberculosis; a treatable, preventable disease that is still the commonest cause of death from an infectious disease.
March 22, 2024
World TB Day 2024 is a moment to take stock of developments in the fight to end tuberculosis; a treatable,...
March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet are still infective, according to a study led by Amsterdam UMC, published in the Lancet.
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet...
March 1, 2024
Dr Ben Swift says Actiphage could provide breakthrough test-of-cure for TB treatment.
Dr Ben Swift says Actiphage could provide breakthrough test-of-cure for TB treatment.